Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Covance
Covance
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
Pharma outsourcing mergers and acquisitions set for record year in 2015
Value of pharmaceutical outsourcing merger and acquisition deals has more than doubled from US$5.5bn in 2014 to $12bn by October 2015
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Focus turns to pre-empting disease causes and ageing
Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved
Manufacturing
Covance expands global biologics capabilities
New investments in facilities and scientific leadership reflect commitment to biologics development
Analysis
Covance and PathoQuest collaborate on NGS-based biosafety assessments
Innovative biosafety testing approach provides a flexible testing solution to all biotherapeutic clients
Regulatory
Covance and Indiana Clinical and Translational Sciences Institute to conduct early clinical trials
Two organisations will conduct high-quality research in a safe and regulated environment for sponsors who are looking to recruit both healthy volunteers and patients
Regulatory
Steve Street joins Covance
Will oversee worldwide safety assessment and pharmaceutical chemistry services
Finance
Covance and sanofi-aventis finalise r&d alliance
Covance also acquires sanofi-aventis plants in France and the UK
Subscribe now